Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma

Clinical trial NCT00215462 · COMPLETED

Trial details

NCT number: NCT00215462
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Gastric Cancer Stomach Cancer

Start date: 2000-06-01
Primary completion: 2005-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.